Wednesday, February 24, 2021

SourceBio chosen to manage mobile COVID-19 testing service

SourceBio International plc, the Nottingham-based provider of laboratory services and products, has entered into an agreement with Mitie Security Limited to manage the delivery of community based COVID-19 testing services through mobile testing units. 

SourceBio will manage the delivery of the mobile COVID-19 testing laboratory service currently being deployed in a Department of Health and Social Care (DHSC) pilot scheme.

SourceBio will oversee all laboratory operations and processes and will have responsibility for all clinical governance, quality assurance, staff training, sample processing and information management.

Currently four mobile testing laboratories using Oxford Nanopore’s LamPORE tests for COVID-19 have been deployed in the pilot which has been launched to support the Government’s community-based testing efforts and ensure that COVID-19 testing is available for surge or increased infectious status within a specified region.

SourceBio will manage the mobile testing service on behalf of Mitie for the remainder of the pilot and is working towards continued involvement in a potential UK-wide programme. 

Larger mobile testing units can process in excess of 1,500 samples a day, with 1,000 tests a day targeted for smaller vehicles. Patient swab samples are processed onboard with results provided within 24 hours.

SourceBio has worked closely with the DHSC providing COVID-19 antigen RT-PCR testing services using the Company’s laboratory facility. The company has processed approaching 1,000,000 COVID-19 antigen RT-PCR tests for the DHSC and the NHS, Private Hospital Groups and Commercial customers since first offering its service in May 2020.

Jay LeCoque, Executive Chairman, said: “We are very proud to support the UK’s national testing effort to bring gold standard testing to the local communities as part of the effort to get the nation back to work.

“The need for localised testing and monitoring of infections is critical as the vaccine program accelerates. This project also highlights our continued work with the DHSC on multiple fronts as they work to manage the pandemic as it evolves.” 

A message from the Editor:

Thank you for reading this story on our news site - please take a moment to read this important message:

As you know, our aim is to bring you, the reader, an editorially led news site and magazine but journalism costs money and we rely on advertising, print and digital revenues to help to support them.

With the Covid-19 pandemic having a major impact on our industry as a whole, the advertising revenues we normally receive, which helps us cover the cost of our journalists and this website, have been drastically affected.

As such we need your help. If you can support our news sites/magazines with either a small donation of even £1, or a subscription to our magazine, which costs just £33.60 per year, (inc p&P and mailed direct to your door) your generosity will help us weather the storm and continue in our quest to deliver quality journalism.

As a subscriber, you will have unlimited access to our web site and magazine. You'll also be offered VIP invitations to our events, preferential rates to all our awards and get access to exclusive newsletters and content.

Just click here to subscribe and in the meantime may I wish you the very best.

Latest news

Related news

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.